Osteoporosis with hip fracture, necrosis of femoral head, congenital dysplasia of hip joint
Conditions
Interventions
Group B:alendronate vitamin D3
Sponsors
Third Hospital of Hebei Medical University
Eligibility
Sex/Gender
Female
Age
50 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. The patient is preoperatively diagnosed as a disease requiring hip replacement; 2. Menopausal women who are older than 50 years old and younger than 80 years old; 3. The scope of operation is unilateral hip replacement; 4. Those who are not combined with severe cardiovascular and cerebrovascular diseases, liver and kidney insufficiency or malignant tumors and can tolerate surgery; 5. No history of long-term bed rest before the injury; 6. Patients voluntarily sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Combined with severe cardiovascular and cerebrovascular diseases, liver and kidney insufficiency or malignant tumors; 2. Those who have received osteoporosis drug therapy within 2-3 months before operation; 3. People who are bedridden for a long time.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bone mineral density;Type 1 Collagen N-terminal Extended Peptide;ß-Collagen Degradation Products;Serum total calcium; | — |
Countries
China
Contacts
Public ContactTao Wu
Third Hospital of Hebei Medical University
Outcome results
None listed